The reliability, validity and responsiveness of the Thai version of systemic lupus erythematosus quality of life (SLEQOL-TH) instrument

Lupus

Volumn 22, Issue 3, 2013, Pages 289-296

  Kasitanon, N ^a   Wangkaew, S ^a   Puntana, S ^a   Sukitawut, W ^a   Leong, K P ^b   Louthrenoo, W ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

HRQoL; outcome assessment; SLE; SLEQOL

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL ITEM FUNCTIONING; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SENSITIVITY AND SPECIFICITY; SLEDAI; SLEQOL TH; SYSTEMIC LUPUS ERYTHEMATOSUS; TEST RETEST RELIABILITY; THAILAND;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84874438773     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312474702     Document Type: Article

References (36)

1. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Endpoints: Consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus. 2000 ; 9: 322-327
2. Last JM, ed. A dictionary of epidemiology. 4th ed. New York: Oxford University Press, 2001.
3. Burckhardt CS, Archenholtz B, Bjelle A. Quality of life of women with systemic lupus erythematosus: A comparison with women with rheumatoid arthritis. J Rheumatol. 1993 ; 20: 977-981
4. Stoll T, Gordon C, Seifert B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 1997 ; 24: 1608-1614
5. Thumboo J, Feng PH, Boey ML, Soh CH, Thio S, Fong KY. Validation of the Chinese SF-36 for quality of life assessment in patients with systemic lupus erythematosus. Lupus. 2000 ; 9: 708-712
6. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001 ; 28: 525-532
7. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol. 1999 ; 26: 490-497
8. Stamm TA, Bauernfeind B, Coenen M, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum. 2007 ; 57: 1287-1295
9. Murawski MM, Miederhoff PA. On the generalizability of statistical expressions of health related quality of life instrument responsiveness: A data synthesis. Qual Life Res. 1998 ; 7: 11-22
10. Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med. 1996 ; 334: 835-840
11. Grootscholten C, Ligtenberg G, Derksen RH, et al. Health-related quality of life in patients with systemic lupus erythematosus: Development and validation of a lupus specific symptom checklist. Qual Life Res. 2003 ; 12: 635-644
12. Leong KP, Kong KO, Thong BY, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford). 2005 ; 44: 1267-1276
13. McElhone K, Abbott J, Shelmerdine J, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007 ; 57: 972-979
14. Doward LC, McKenna SP, Whalley D, et al. The development of the L-QoL: A quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis. 2009 ; 68: 196-200
15. Jolly M, Pickard AS, Block JA, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 ; 42: 56-65
16. Kong KO, Ho HJ, Howe HS, et al. Cross-cultural adaptation of the Systemic Lupus Erythematosus Quality of Life Questionnaire into Chinese. Arthritis Rheum. 2007 ; 57: 980-985
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
18. Gladman DD, Goldsmith CH, Urowitz MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol. 2000 ; 27: 373-376
19. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 ; 29: 288-291
20. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000 ; 25: 3186-3191
21. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994 ; 47: 81-87
22. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care. 1990 ; 28: 632-642
23. Bjorner JB, Kreiner S, Ware JE, Damsgaard MT, Bech P. Differential item functioning in the Danish translation of the SF-36. J Clin Epidemiol. 1998 ; 51: 1189-1202
24. Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus. 1998 ; 7: 101-107
25. Burckhardt CS, Archenholtz B, Bjelle A. Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: A Swedish version of the Quality of Life Scale (QOLS). Scand J Rheumatol. 1992 ; 21: 190-195
26. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. Lack of correlation among the 3 outcomes describing SLE: Disease activity, damage and quality of life. Clin Exp Rheumatol. 1996 ; 14: 305-308
27. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus. 1996 ; 5: 190-195
28. Hanly JG. Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: Results of a cross-sectional study. Lupus. 1997 ; 6: 243-247
29. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: An update. Ann Acad Med Singapore. 2007 ; 36: 115-122
30. Schmidt S, Bullinger M. Current issues in cross-cultural quality of life instrument development. Arch Phys Med Rehabil. 2003 ; 84: S29 - S34
31. Kristjansson EA, Desrochers A, Zumbo B. Translating and adapting measurement instruments for cross-linguistic and cross-cultural research: A guide for practitioners. Can J Nurs Res. 2003 ; 35: 127-142
32. Lenderking WR. Comments on the ISPOR Task Force Report on Translation and Adaptation of Outcomes Measures: Guidelines and the need for more research. Value Health. 2005 ; 8: 92-93
33. Strand V, Crawford B. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoecon Outcomes Res. 2005 ; 5: 317-326
34. Jolly M, Pickard AS, Wilke C, et al. Lupus-specific health outcome measure for US patients: The LupusQoL-US version. Ann Rheum Dis. 2010 ; 69: 29-33
35. Touma Z, Gladman DD, Ibañez D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?. J Rheumatol. 2011 ; 38: 1898-1905
36. Chaiamnuay S, Lomaratana V, Sumransurp S, Phukongchai S, Narongroeknawin P, Asavatanabodee P. Health-related quality of life and disease severity of SLE patients in Phramongkutklao Hospital. J Med Assoc Thai. 93 ; (Suppl 6). S125 - S130